Our team
FOUNDER AND MANAGING DIRECTOR
VASAVI VITTALI
Vasavi brings over two decades of cross-disciplinary experience spanning venture capital, private equity, and public markets, with a deep foundation in healthcare, biotech and pharma.
Prior to founding Liberty Ridge Capital, Vasavi was Portfolio Manager and Head of Healthcare Investments at ICM Global Funds. She has successfully led investments across early-stage and growth-stage healthcare companies, set the investment mandate, and served on boards, providing strategic guidance and operational oversight.
Her unique blend of scientific expertise, financial acumen, and strategic insight enables her to identify compelling opportunities and to partner meaningfully with founders and management teams. Vasavi is known for her disciplined investment approach, grounded in real-world value creation and long-term vision.
Vasavi holds an MBA from the University of Oxford and an M.S. in Biochemistry from the University of Maryland. Having lived and worked across India, the US, UK and now Singapore, Vasavi brings a global perspective and a deep commitment to building healthcare companies that make a lasting impact.
PARTNER
SUSHANTH YELLAPANTULLA
Suhanth is a pharmaceutical industry leader with over 14 years of global experience spanning business development, corporate strategy, and operational leadership. He is also the Founder and Managing Partner of Connecting Dots FZCO, a boutique consulting firm that partners with early-stage biopharmaceutical companies to develop go-to-market strategies and secure growth capital.
Prior to founding Connecting Dots, Sushanth was a core member of the founding team at GeneSys Biologics, where he spent nearly a decade in senior leadership roles. He was instrumental in building the company from the ground up, leading strategic initiatives that resulted in over $50 million in equity financing and structuring licensing partnerships valued at more than $200 million over five years. He continues to be actively involved with strategic initiatives at GeneSys.
Sushanth began his career at RA Chem Pharma Ltd (now Cohance Life Sciences), where he quickly rose to lead the P&L of the clinical research division and drove key R&D initiatives as part of the executive team.
He holds a Master’s degree in Pharmacology from King’s College London and remains an active member of its Indian alumni network